Clinical observation of Yishentongjing Decoction sequential therapy in the treatment of low menstrual flow with liver depression and kidney deficiency after abortion
益肾通经汤序贯疗法治疗人流术后肝郁肾虚型月经量少的临床观察

摘要

目的 研究益肾通经汤序贯疗法治疗人流术后肝郁肾虚型月经量少患者的临床效果。方法 本研究作者选择的100例研究对象均来源于2020年5月-2022年5月期间我院收治的人流术后肝郁肾虚型月经量少患者，样本选择完毕后，按照随机数字表法分组，分别为：观察组和对照组，各组均由50例患者组成，对照组患者通过常规激素序贯疗法进行治疗，观察组患者在此基础上，联合益肾通经汤进行治疗，比较两组患者的治疗总有效率；治疗前后的血清性激素水平（FSH（促卵泡生长激素）、LH（促黄体生长素）、E2（雌二醇）、P（孕酮））；治疗前后的行经时间、子宫内膜厚度；不良反应发生率（恶心呕吐、头晕、腹痛）。结果 观察组患者的治疗总有效率更高（P＜0.05）；治疗后，观察组患者的血清性激素水平更优（P＜0.05）；治疗后，观察组患者的行经时间、子宫内膜厚度多于对照组患者（P＜0.05）；两组患者的不良反应发生率比较（P＞0.05）。结论 人流术后肝郁肾虚型月经量少患者通过益肾通经汤序贯疗法治疗，能够有效提升临床疗效，改善患者激素，延长行经时间，增加子宫内膜厚度，安全性高，值得推广。

Abstract

Objective To investigate the clinical effect of Yishentongjing Decoction sequential therapy in patients with low menstrual flow with liver depression and kidney deficiency after abortion.
Methods The 100 patients selected by the authors of this study were all from patients with low menstrual flow after abortion from May 2020 to May 2022. After the selection of samples, they were divided into two groups according to random number table method: observation group and control group. Each group consisted of 50 patients. Patients in the control group were treated with conventional sequential hormone therapy, and patients in the observation group were treated with Yishentongjing Decoction on this basis. The total effective rate, serum sex hormone levels before and after treatment (FSH (follicle-stimulating growth hormone), LH (luteinizing auxin), E2 (estradiol), P (progesterone)); menstrual travel time before and after treatment, endometrial thickness; incidence of adverse reactions (nausea, vomiting, dizziness, abdominal pain) were compared.
Results The total effective rate of patients in the observation group was higher (P<0.05), the serum sex hormone level in the observation group was better (P<0.05) after treatment, the menstrual time and endometrial thickness of the observation group were higher than those in the control group (P<0.05) after treatment, and the incidence of adverse reactions between the two groups was compared (P>0.05).
Conclusion   Patients with low menstrual flow with liver depression and kidney deficiency after abortion can effectively improve clinical efficacy, improve hormones, prolong menstrual time, increase endometrial thickness, and have high safety and are worthy of promotion.